LRFN3 Peptide Reference: GTX85343-PEP LRFN3 peptide is used for blocking the activity of LRFN3 antibody (catalog number GTX85343). It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 3 min at 37oC.
Recombinant Human GDF-11 / BMP-11 (Animal-Free) Reference: GFH57AF-5 Growth Differentiation Factor 11 (GDF-11), also known as BMP-11, is a regulator of cell growth and differentiation during muscular and neural development. GDF-11 binds the Transforming Growth Factor β receptors ALK4, ALK5, and ALK7 to activate SMAD signaling. In adults, exogenous GDF-11 promotes cardiomyocyte regeneration to reverse age-related cardiac hypertrophy.
LRFN2 Peptide Reference: GTX85344-PEP LRFN2 peptide is used for blocking the activity of LRFN2 antibody (catalog number GTX85344). It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 3 min at 37oC.
Recombinant Human GDF-11 / BMP-11 (Animal-Free) Reference: GFH57AF-20 Growth Differentiation Factor 11 (GDF-11), also known as BMP-11, is a regulator of cell growth and differentiation during muscular and neural development. GDF-11 binds the Transforming Growth Factor β receptors ALK4, ALK5, and ALK7 to activate SMAD signaling. In adults, exogenous GDF-11 promotes cardiomyocyte regeneration to reverse age-related cardiac hypertrophy.
LRFN1 Peptide Reference: GTX85345-PEP LRFN1 peptide is used for blocking the activity of LRFN1 antibody (catalog number GTX85345). It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 3 min at 37oC.
Recombinant Human GDF-11 / BMP-11 (Animal-Free) Reference: GFH57AF-100 Growth Differentiation Factor 11 (GDF-11), also known as BMP-11, is a regulator of cell growth and differentiation during muscular and neural development. GDF-11 binds the Transforming Growth Factor β receptors ALK4, ALK5, and ALK7 to activate SMAD signaling. In adults, exogenous GDF-11 promotes cardiomyocyte regeneration to reverse age-related cardiac hypertrophy.
GNPDA2 Peptide Reference: GTX85346-PEP GNPDA2 peptide is used for blocking the activity of GNPDA2 antibody (catalog number GTX85346). It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 3 min at 37oC.
Recombinant Human GDF-11 / BMP-11 (Animal-Free) Reference: GFH57AF-1000 Growth Differentiation Factor 11 (GDF-11), also known as BMP-11, is a regulator of cell growth and differentiation during muscular and neural development. GDF-11 binds the Transforming Growth Factor β receptors ALK4, ALK5, and ALK7 to activate SMAD signaling. In adults, exogenous GDF-11 promotes cardiomyocyte regeneration to reverse age-related cardiac hypertrophy.
FNIP2 Peptide Reference: GTX85347-PEP FNIP2 peptide is used for blocking the activity of FNIP2 antibody (catalog number GTX85347). It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 3 min at 37oC.
Recombinant Human GDF-15 Reference: GFH171-5 Growth Differentiation Factor 15 (GDF-15) is a member of the Transforming Growth Factor β (TGF-β) family and is made by the placenta and cardiovascular tissues. GDF-15 regulates inflammatory and apoptotic pathways during cellular stress and injury. GDF-15 is emerging as a biomarker of early heart disease, such that increased levels of circulating GDF-15 are associated with an increased risk of developing heart failure.
FNIP2 Peptide Reference: GTX85348-PEP FNIP2 peptide is used for blocking the activity of FNIP2 antibody (catalog number GTX85348). It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 3 min at 37oC.
Recombinant Human GDF-15 Reference: GFH171-20 Growth Differentiation Factor 15 (GDF-15) is a member of the Transforming Growth Factor β (TGF-β) family and is made by the placenta and cardiovascular tissues. GDF-15 regulates inflammatory and apoptotic pathways during cellular stress and injury. GDF-15 is emerging as a biomarker of early heart disease, such that increased levels of circulating GDF-15 are associated with an increased risk of developing heart failure.